The U.S. authorities on Monday filed an emergency movement to remain a decide’s ruling to revoke the Meals and Drug Administration’s 23-year-old approval of the abortion capsule mifepristone, a ruling that would make it tougher for sufferers to bear the process.

In a submitting with the fifth U.S. Circuit Court docket of Appeals in New Orleans, the Division of Justice mentioned the decide’s ruling was “particularly unwarranted” as a result of it could thwart the FDA’s scientific judgment and severely hurt ladies, particularly these for whom mifepristone is a medical or sensible necessity.

Monday’s submitting got here three days after U.S. District Choose Matthew Kacsmaryk in Amarillo, Texas, mentioned the FDA had exceeded its authority by ignoring mifepristone’s dangers and counting on “plainly unsound reasoning and research” when approving it.

The decide, an appointee of Republican former President Donald Trump, stayed his preliminary injunction for seven days to permit the Biden administration time to enchantment.